Narcissus and Daffodil

354 D. Brown
Snorrason, E. and Stefansson, J.G. (1991) Galanthamine hydrobromide in mania. Lancet,
337, 557.
Sweeney, J.E., Bachman, E.S. and Coyle, J.T. (1990) Effects of different doses of galanthamine,
a long acting acetylcholinesterase inhibitor, on memory in mice. Psychopharmacology,
102 (2), 191–200.
Sweeney, J.E., Hohmann, C.F., Moran, T.H. and Coyle, J.T. (1988) A long-acting cholinesterase
inhibitor reverses spatial memory deficits in mice. Pharmacology, Biochemistry and
Behaviour, 31 (1), 141–147.
Sweeney, J.E., Puttfarcken, P.S. and Coyle, J.T. (1989) Galanthamine, an acetylcholinesterase
inhibitor: a time course of the effects on performance and neurochemical parameters
in mice. Pharmacology, Biochemistry and Behaviour, 34 (1), 129–137.
Tassonyi, E., Labancz, K., Vimlati, L. and Kiss, I. (1976) Postoperative apnoea following
nivalin administration. Der Anaesthesist, 25, 529–531.
Thomsen, T., Bickel, U., Fischer, J.P. and Kewitz, H. (1990a) Stereoselectivity of cholinersterase
inhibition by galanthamine and tolerance in humans. European Journal of
Clinical Pharmacology, 39 (6), 603–605.
Thomsen, T., Bickel, U., Fischer, J.P. and Kewitz, H. (1990b) Galanthamine hydrobromide
in a long-term treatment of Alzheimer’s disease. Dementia, 1 (1), 46–51.
Thomsen, T., Kaden, B., Fischer, J.P., Bickel, U., Barz, H., Gusztomy, G., Cervos-Navarro, J.
and Kewitz, H. (1991a) Inhibition of acetylcholinesterase activity in human brain tissue
and erythrocytes by galanthamine, phytostigmine and tacrine. European Journal of Clinical
Chemistry and Clinical Biochemistry, 29 (8), 487–492.
Thomsen, T. and Kewitz, H. (1990) Selective inhibition of human acetylcholinesterase by
galanthamine in vitro and in vivo. Life Science, 46 (21), 1553–1558.
Thomsen, T., Zendeh, B. and Fischer, J.P. (1991b) In vitro effects of various cholinesterase
inhibitors on acety- and butyrylcholinesterase of healthy volunteers. Biochemistry and
Pharmacology, 41 (1), 139–141.
Tonkopii, V.D., Prozorovskii, V.B. and Suslova, I.M. (1976) Interaction of reversible inhibitors
with catalytic centres and allosteric sites of cholinesterases. Bulletin of Experimental
Biology in Medicine, 82, 1331–1334.
Tonkopii, V.D. and Padinker, E.P. (1995) Effect of anticholinesterases on thermal denaturation
of cholinesterases. Bulletin of Experimental Biology in Medicine, 86, 400–401.
Umarova, S.S., Zakirov, U.B. and Kamilov, I.K. (1965) Comparative evaluation of the
pharmacological action of quaternary galanthamine derivatives. Farmakologiya Alkaloidova
Akademia Nauk USSR, 2, 258–263 (Chemical Abstracts, 66, 53993).
Uyeo, S. and Kobayashi, S. (1953) [Untitled.] Chemical and Pharmaceutical Bulletin (Tokyo), 1, 139.
Vigneau, C., Tsao, J., Ducluzeau, R. and Balzot, J. (1984) Two clinical cases of daffodil
poisoning. Journal of Toxicology and Medicine, 4 (1), 21–26.
Vovin, R.Y., Fakturovich, A.Y., Golenkov, A.V. and Lukin, V.O. (1991) Correction of akinetic-abulic
syndrome in schizophrenics using cholinotropic drugs. Zhurnal Neuropatologii
i Psikhiatrii (Moskva), 91, 111–115.
Westra, P., Van Thiel, M.J.S., Vermeer, G.A., Soeterbroeck, A.M., Scaf, A.H.J. and Claessens,
H.A. (1986) Pharmacokinetics of galanthamine (a long acting anticholinesterase
drug) in anaesthetised patients. British Journal of Anaesthesia, 58 (11), 1303–1307.
Wislicki, L. (1967) Nivalin (galanthamine hydrobromide), an additional decurarizing agent.
Some introductory observations. British Journal of Anaesthesia, 39 (12), 963–968.
Yonkov, D.I. and Georgiev, V.P. (1990) Cholinergic influence on memory facilitation
induced by angiotensin II in rats. Neuroleptics, 16, 157–162.